US EditionInnovent to Present Preclinical Data of Multiple Novel Molecules at the 2025 AACR Annual Meeting
- Innovent Biologics will present preclinical data on novel bispecific antibodies and antibody-drug conjugates at the AACR Annual Meeting from April 25 to April 30, 2025, in Chicago, Illinois.
- Innovent has launched 15 products, with 3 new drug applications under regulatory review and 16 more molecules in early clinical stages.
- Dr. Kaijie He of Innovent stated, 'We are proud to showcase a batch of preclinical research findings at this year's AACR Annual Meeting,' highlighting their advancing R&D capabilities.
- Innovent partners with over 30 global healthcare companies, including Eli Lilly and Sanofi, to enhance its biopharmaceutical development and commercialization processes.
Insights by Ground AI
Does this summary seem wrong?
22 Articles
22 Articles
All
Left
2
Center
10
Right
Napa Valley Register+20 Reposted by 20 other sources
Innovent to Present Preclinical Data of Multiple Novel Molecules at the 2025 AACR Annual Meeting
SAN FRANCISCO and SUZHOU, China, March 26, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other…
Coverage Details
Total News Sources22
Leaning Left2Leaning Right0Center10Last UpdatedBias Distribution83% Center
Bias Distribution
- 83% of the sources are Center
83% Center
L 17%
C 83%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
